reference/10232495

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10232495

Outgoing Links

Predicate	Object
contentType	Letter\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	602
issn	0028-4793 1533-4406
issueIdentifier	6
pageRange	601-602
publicationName	The New England journal of medicine
startingPage	601
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3a55f853ae4d08ee94f27b95f01c5597 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0334d1ae1dd47974f3d6db5b72da57b6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7ebd16953c44a245f41a1fa9db42abef http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0077114e5b219c7582e5184d04a159b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_847374ced4fb22809f8e2849cf6aa081
bibliographicCitation	Pries-Heje MM, Wiingaard C, Ihlemann N, Gill SU, Bruun NE, Elming H, Povlsen JA, Madsen T, Jensen KT, Fursted K, Schultz M, Østergaard L, Christensen JJ, Christiansen U, Rosenvinge F, Helweg-Larsen J, Fosbøl EL, Køber L, Torp-Pedersen C, Tønder N, Moser C, Iversen K, Bundgaard H. Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial. N Engl J Med. 2022 Feb 10;386(6):601–2. doi: 10.1056/nejmc2114046. PMID: 35139280.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c0f010520b8c340bda1696b0a9e9851 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8552633ed8f90ff5ddb4a0437adad29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63afac3b1c105ac1a0e599c36460d30f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c6597a0f9e4ba02af97b1602d1c7049 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7738404a48bbdb791bcb09fcdc903f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2892-6131 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_726414df4f54b0f4abbc66a4055d955a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b4a3ff162a19264cc816aac63c71634 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d157ad1e253fcb61585f7da590d4999 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b39f713bdfeef6e298839c53789f96b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9655-0493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65de66746abbb92a856afeab46c704f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6aedb58efd9b581f11b4e95b0adc34d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_233ca14283fd947392575f36cf2902fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df695888b2ec36822018d3a895ff841a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f80b301938d8b7e9ad8b964974e10c93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_deb24e33181cb1e273ba699cb234d1d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99629ca09eb887fffd4b6f4fa703ab4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1259-645X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7ff35c857ed321af6dcefbf68fef7e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13c6bfa41cc188ee34b6b64d25ea71c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0763cc6688995289dd66ea73a32e475 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_031b946623cde5afd38d1ab354277c35
date	2022-02-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/35139280 https://doi.org/10.1056/nejmc2114046
isPartOf	https://portal.issn.org/resource/ISSN/1533-4406 https://portal.issn.org/resource/ISSN/0028-4793 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial
discusses	http://id.nlm.nih.gov/mesh/M0448397
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000900Q000008 http://id.nlm.nih.gov/mesh/D004697Q000188 http://id.nlm.nih.gov/mesh/D000284
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061605 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004697Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005500

Showing number of triples: 1 to 56 of 56.